IGFBP2 and central nervous system cancer: Rahman et al. demonstrated that IGFBP2 could induce the increase of glioma invasion and malignancy by activating PTEN and AKT pathways, which is enhanced by HIF-α associated with promoting glycolysis related activities (Rahman and Thomas, 2011; Das et al., 2013).